Equity Securities (Details Narrative) - USD ($)
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
|
|
|
Jul. 12, 2021 |
Jun. 29, 2021 |
Mar. 15, 2021 |
Jun. 14, 2019 |
Apr. 25, 2022 |
Aug. 31, 2021 |
Aug. 17, 2021 |
Mar. 31, 2021 |
Mar. 24, 2021 |
Oct. 31, 2020 |
Jun. 30, 2020 |
May 31, 2020 |
Nov. 30, 2016 |
Mar. 31, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2016 |
Jun. 30, 2022 |
Aug. 14, 2021 |
Jul. 31, 2021 |
Jul. 30, 2021 |
Jul. 01, 2021 |
Jun. 30, 2021 |
Mar. 23, 2021 |
Dec. 31, 2020 |
Mar. 31, 2020 |
Jun. 30, 2019 |
Mar. 31, 2017 |
Feb. 28, 2017 |
Dec. 31, 2015 |
Common stock, shares available for issuances |
|
593,340
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,648,213
|
|
|
|
|
|
|
|
|
Pre-funded warrants to purchase common share |
|
|
|
|
2,875,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,906,244
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net consideration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,833,877
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Evergreen provision resulted in increase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
83,286
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increasing shares authorized for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,731,499
|
|
|
|
|
|
|
250,000,000
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,102,214
|
|
8,328,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stocks, authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90,000,000
|
|
90,000,000
|
|
|
|
|
90,000,000
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,957,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, expire date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
August 17, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred unit interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, Conversion of Stock, Shares Converted |
|
|
|
|
|
|
65,823,015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,102,214
|
|
8,328,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of difference |
The Company compared the fair value of the Series 1d Preferred Stock, as amended, to its carrying value and recorded the resulting difference of approximately $2.3 million as a deemed dividend for the Series 1d preferred shareholders.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividend |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,200,000
|
|
|
$ 2,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,221,156
|
|
5,221,156
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 709,435
|
$ 1,416,691
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Conversion, Converted Instrument, Principal Amount |
|
|
|
|
|
|
|
|
|
$ 1,145,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 87
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
stock-based compensation expense |
|
|
|
|
|
|
|
|
$ 849,564
|
|
|
|
|
|
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board of Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentages of initial public per share offering price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
80.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of reverse split |
|
1-for-20.5 reverse split
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 20.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, issued |
|
|
|
|
|
69,212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriter IPO Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, expire date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
August 17, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
128,571
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase share of common stock |
|
|
|
|
|
128,571
|
|
|
|
|
|
|
|
|
128,571
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase share of common stock, Exercise price Percentage of public offering price |
|
|
|
|
|
115.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase share of common stock, Exercise price |
|
|
|
|
|
$ 8.05
|
|
|
|
|
|
|
|
|
$ 8.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 1d Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price per share |
|
|
|
|
|
|
|
$ 0.83
|
|
|
|
|
|
$ 0.83
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
686,742
|
|
|
|
|
|
686,742
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of preferred units |
|
|
|
|
|
|
|
$ 570,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subordinated convertible promissory notes interest |
|
|
$ 73,801
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subordinated convertible promissory notes |
|
|
$ 4,391,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subordinated convertible promissory notes converted into shares units |
|
|
5,379,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 1a Preferred Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,018,750
|
|
|
|
|
|
Preferred stock, Conversion of Stock, Shares Converted |
|
|
|
|
|
1,419,228
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
$ 20.50
|
|
|
|
|
|
20.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of preferred units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant units to purchase stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants exercised |
|
|
|
|
|
|
|
|
|
|
18,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consideration of warrants exercised |
|
|
|
|
|
|
|
|
|
|
$ 18,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Conversion of Stock, Warrant Exercisable |
|
|
|
|
|
69,212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 1c Preferred Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46,553,188
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,221,156
|
|
|
|
Net of issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,857
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing from current and new investors |
|
|
|
$ 5,785,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,535,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash received from conversion of convertible note issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued interest on the convertible note |
|
|
|
1,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining balance committed to financing payable amount |
|
|
|
$ 250,000
|
|
|
|
|
|
|
125,000
|
$ 125,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock and Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,911,009
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
$ 0.0001
|
|
|
$ 5.74
|
|
|
|
|
|
$ 5.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PIPE Common Stock, Conversion of Stock, Shares Issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,773,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Conversion of Stock, Shares Issued |
|
|
|
|
|
3,813,973
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriters' discounts and offering expenses |
|
|
|
|
$ 700,000
|
|
$ 2,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred and common stock par value per share |
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares sold |
|
|
|
|
898,585
|
2,571,428
|
2,571,428
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre funded |
|
|
|
|
2,875,000
|
|
|
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
875,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre funded outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock |
|
|
|
|
|
2,957,142
|
2,571,428
|
|
|
|
|
|
|
|
3,773,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock, Exercise price |
|
|
|
|
$ 1.325
|
|
$ 7.00
|
|
|
|
|
|
|
|
$ 1.325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price |
|
|
|
|
|
|
7.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised to purchase additional warrants, Exercise price |
|
|
|
|
|
|
$ 7.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance initial public offering |
|
|
|
|
$ 4,300,000
|
|
$ 15,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock and Preferred Stock | Convertible Promissory Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Conversion, Converted Instrument, Principal Amount |
|
|
|
|
|
$ 175,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Conversion of Stock, Shares Issued |
|
|
|
|
|
32,219
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Conversion, Converted Instrument, Accrued Interest |
|
|
|
|
|
$ 5,434
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class B Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,767,477
|
|
|
|
|
|
Common units issued |
|
|
|
|
|
|
|
22,494
|
|
|
|
|
|
22,494
|
|
|
|
|
|
|
|
|
|
|
|
|
|
133,953
|
2,439
|
|
|
|
|
Common units issued consideration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,853
|
|
|
|
|
|
Common units issued as profits interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
365,245
|
|
|
|
|
|
Thresholds price per share minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
|
|
Class B common unit issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,268,279
|
|
|
|
|
|
Thresholds price per share maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.36
|
|
|
|
|
|
Class B Common Units | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
$ 0.52
|
|
|
|
|
$ 5.74
|
|
|
|
|
|
$ 5.74
|
$ 5.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 279,812
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of stock units into warrants, shares issued |
|
|
|
|
|
|
|
65,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common and Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
898,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre funded outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,773,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock, Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,773,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 1b Preferred Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of preferred units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net of issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 40,405
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common units issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,268,279
|
|
|
|
|
|
Estimated fair value of common stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,340,000
|
|
|
|
|
|
Series 1b Preferred Units | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
$ 5.74
|
|
|
|
|
|
$ 5.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of warrant |
|
|
|
|
|
|
|
$ 65,303
|
|
|
|
|
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consideration of warrants exercised |
|
|
|
|
|
|
|
|
|
|
$ 18,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net issuance cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 19,868
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock units, fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
618,801
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
up to an aggregate number of Series 1a Preferred Units not to exceed the product of 25% and the aggregate number of Series 1a Preferred Units then held by such Series 1a Preferred Member, which was 1,231,250 units at December 31, 2020. The exercise price for each Warrant Unit was $1.00, subject to adjustment for unit splits and combinations. The warrants had a 5-year term.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
stock-based compensation expense |
|
|
|
|
|
|
|
$ 279,812
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,381,199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, exercised during period |
|
|
|
|
|
|
|
|
|
|
18,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common units issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
508,777
|
Consideration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,430
|
Loan and Security Agreement with Silicon Valley Bank | Series 1a Preferred Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.00
|
|
Warrant units to purchase stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
187,978
|
|
License Agreement | Villani, Inc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.0
|
|
|
Preferred Units, surrendered |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,221,156
|
|
|
|
|
|
|
|
|
|
Carrying value |
|
|
|
|
|
|
730,962
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividend |
|
|
|
|
|
|
$ 269,038
|
|
|
|
|
|
|
|
$ 269,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan and Security Agreement | Series 1a Preferred Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.00
|
|
|
|
|
|
|
Warrant units to purchase stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
187,978
|
|
|
|
|
|
|
IPO | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,957,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant units to purchase stocks |
|
|
|
|
|
|
2,957,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares sold |
|
|
|
|
|
|
2,571,428
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock |
|
|
|
|
|
|
2,571,428
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock, Exercise price |
|
|
|
|
|
|
$ 7.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,957,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
7.00
|
|
|
|
|
|
|
|
$ 7.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price |
|
|
|
|
|
|
$ 7.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional shares of warrant |
|
|
|
|
|
|
385,714
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing trading price |
|
|
|
|
|
|
$ 0.9995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|